Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteosarcoma in blood relatives.

A Longhi1, M S Benassi, L Molendini

  • 1Service of Chemotherapy, Istituti Ortopedici Rizzoli, 40136 Bologna, Italy. alessandra.longhi@ior.it

Oncology Reports
|December 15, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience.

BMC cancer·2023
Same author

Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)<sup>☆</sup>.

ESMO open·2021
Same author

Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients.

Acta oncologica (Stockholm, Sweden)·2018
Same author

Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients.

European journal of cancer (Oxford, England : 1990)·2017
Same author

Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone.

BMC cancer·2016
Same author

Long-term efficacy of microbiology-driven periodontal laser-assisted therapy.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2016
Same journal

Identification of RRM2 as a key regulator of malignant epithelial cells in gastric cancer through single‑cell transcriptomics.

Oncology reports·2026
Same journal

Impact of WFDC2 on the biological functions of cervical cancer cells and the regulation of the ERK/NF‑κB signaling pathway.

Oncology reports·2026
Same journal

Schisandrin B exhibits anti‑proliferative effects by inducing ferroptosis in pancreatic cancer.

Oncology reports·2026
Same journal

Research advances on DKK1 in head and neck squamous cell carcinoma: Linking molecular mechanisms to clinical applications (Review).

Oncology reports·2026
Same journal

PI3Kδ inhibitor YY‑20394 is effective alone or in combination with Bcl‑2 inhibitor ABT199 in acute myeloid leukemia cells.

Oncology reports·2026
Same journal

A fibroblast activation protein degrader enhances cisplatin sensitivity in non‑small cell lung cancer.

Oncology reports·2026
See all related articles

Familial osteosarcoma cases reveal key genetic alterations. Researchers found inactive p53 and loss of Rb protein, confirming specific genetic changes in osteosarcoma development.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Osteosarcoma is a rare bone cancer.
  • Familial occurrence of osteosarcoma is exceptionally uncommon.
  • Understanding the genetic basis of osteosarcoma is crucial for diagnosis and treatment.

Observation:

  • Four cases of familial osteosarcoma (two sibling pairs, one father-son pair) were analyzed.
  • Patients had no prior family history of tumors and negative p53 mutations.
  • Gene expression of RB, CDK4, MDM2, c-myc, c-fos, and p53 was investigated.

Findings:

  • An inactive form of p53 was sporadically observed.
  • A complete loss of Retinoblastoma (Rb) protein expression was detected.
  • Increased expression of Cdk4, MDM2, c-fos, and c-myc proteins was noted.

Related Experiment Videos

Implications:

  • These genetic alterations are consistent with known changes in osteosarcoma pathogenesis.
  • The study confirms specific genetic alterations contribute to osteosarcoma development.
  • Findings may inform future research into familial osteosarcoma and targeted therapies.